Rituximab and Wegener's granulomatosis: are B cells a target in vasculitis treatment?

Arthritis Rheum. 2005 Jan;52(1):1-5. doi: 10.1002/art.20717.
No abstract available

Publication types

  • Comment
  • Editorial
  • Review

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Granulomatosis with Polyangiitis / drug therapy*
  • Humans
  • Rituximab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Rituximab